gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.
作者信息
Nakamura S, Nakamura M, Kojima T, Yoshida H
机构信息
Research Laboratories, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
出版信息
Antimicrob Agents Chemother. 1989 Feb;33(2):254-5. doi: 10.1128/AAC.33.2.254.
Abstract
The proportion of gyrA and gyrB mutations in quinolone-resistant Escherichia coli strains was examined by introducing cloned wild-type gyrA and gyrB genes. In 25 spontaneous mutants of strain KL16, 13 had gyrA and 12 had gyrB mutations. In eight clinical isolates, five had gyrA mutations and one had a gyrB mutation; mutations in two isolates remained unidentified.
摘要
相似文献
1
gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli.
Antimicrob Agents Chemother. 1989 Feb;33(2):254-5. doi: 10.1128/AAC.33.2.254.
2
Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
Antimicrob Agents Chemother. 1995 Aug;39(8):1667-70. doi: 10.1128/AAC.39.8.1667.
3
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Antimicrob Agents Chemother. 1994 Sep;38(9):2014-23. doi: 10.1128/AAC.38.9.2014.
4
Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
FEMS Microbiol Lett. 1993 Jan 15;106(2):187-91. doi: 10.1016/0378-1097(93)90079-h.
5
CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
FEMS Microbiol Lett. 2018 Jul 1;365(13). doi: 10.1093/femsle/fny127.
6
Quinolone-resistant mutations of the gyrA gene of Escherichia coli.
Mol Gen Genet. 1988 Jan;211(1):1-7. doi: 10.1007/BF00338386.
7
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1990 Jun;34(6):1273-5. doi: 10.1128/AAC.34.6.1273.
8
New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Mol Gen Genet. 1989 Oct;219(1-2):306-12. doi: 10.1007/BF00261192.
9
Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes.
J Antimicrob Chemother. 2008 May;61(5):1007-15. doi: 10.1093/jac/dkn077. Epub 2008 Mar 6.
10
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2. doi: 10.1128/AAC.34.6.1271.
引用本文的文献
1
Unpredictability of the Fitness Effects of Antimicrobial Resistance Mutations Across Environments in Escherichia coli.
Mol Biol Evol. 2024 May 3;41(5). doi: 10.1093/molbev/msae086.
2
High prevalence of mcr-1-encoded colistin resistance in commensal Escherichia coli from broiler chicken in Bangladesh.
Sci Rep. 2020 Oct 29;10(1):18637. doi: 10.1038/s41598-020-75608-2.
3
Antibiotic resistance in and adaptation to complex dynamic environments.
Microb Genom. 2020 May;6(5). doi: 10.1099/mgen.0.000370. Epub 2020 Apr 29.
4
Catabolism of aromatic β-glucosides by bacteria can lead to antibiotics resistance.
Arch Microbiol. 2020 Aug;202(6):1301-1315. doi: 10.1007/s00203-020-01836-9. Epub 2020 Mar 4.
5
The mutational landscape of quinolone resistance in Escherichia coli.
PLoS One. 2019 Nov 5;14(11):e0224650. doi: 10.1371/journal.pone.0224650. eCollection 2019.
6
Evolutionary highways to persistent bacterial infection.
Nat Commun. 2019 Feb 7;10(1):629. doi: 10.1038/s41467-019-08504-7.
7
Predictable Phenotypes of Antibiotic Resistance Mutations.
mBio. 2018 May 15;9(3):e00770-18. doi: 10.1128/mBio.00770-18.
8
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years' Experience 1991-2015.
Pharmacoecon Open. 2017 Jun;1(2):123-131. doi: 10.1007/s41669-016-0007-y.
9
Genetic characterization of phenicol-resistant Escherichia coli and role of wild-type repressor/regulator gene (acrR) on phenicol resistance.
Folia Microbiol (Praha). 2018 Jul;63(4):443-449. doi: 10.1007/s12223-017-0579-7. Epub 2018 Jan 6.
10
A population genomics approach to exploiting the accessory 'resistome' of .
Microb Genom. 2017 Apr 6;3(4):e000108. doi: 10.1099/mgen.0.000108. eCollection 2017 Apr.
本文引用的文献
1
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.
J Bacteriol. 1981 Nov;148(2):450-8. doi: 10.1128/jb.148.2.450-458.1981.
2
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Antimicrob Agents Chemother. 1984 Dec;26(6):797-801. doi: 10.1128/AAC.26.6.797.
3
Escherichia coli K-12 mutants resistant to nalidixic acid: genetic mapping and dominance studies.
J Bacteriol. 1969 Jul;99(1):238-41. doi: 10.1128/jb.99.1.238-241.1969.
4
Studies on the mechanism of action of nalidixic acid.
Antimicrob Agents Chemother. 1973 Oct;4(4):479-86. doi: 10.1128/AAC.4.4.479.
5
Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.
J Gen Microbiol. 1985 Sep;131(9):2285-92. doi: 10.1099/00221287-131-9-2285.
6
Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
Antimicrob Agents Chemother. 1986 Aug;30(2):248-53. doi: 10.1128/AAC.30.2.248.
7
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli.
Mol Gen Genet. 1986 Sep;204(3):367-73. doi: 10.1007/BF00331012.
8
Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
Antimicrob Agents Chemother. 1986 Apr;29(4):639-44. doi: 10.1128/AAC.29.4.639.
9
Quinolone-resistant mutations of the gyrA gene of Escherichia coli.
Mol Gen Genet. 1988 Jan;211(1):1-7. doi: 10.1007/BF00338386.
10
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.
Antimicrob Agents Chemother. 1987 Nov;31(11):1861-3. doi: 10.1128/AAC.31.11.1861.
Zotero 插件